Item 4 — Purpose of Transaction
Item 4 of the Schedule 13D is hereby amended and restated in its entirety, and supersedes and replaces in its entirety the Item 4 disclosure in the Original 13D and Amendment No. 1, as follows: June 2025 Warrant Exercise and Amendment. On June 1, 2025, Kaufman Kapital and the Issuer entered into a Warrant Exercise and Amendment to Notes and Warrant Agreement (the "June 2025 Amendment"), pursuant to which: (i) Kaufman Kapital agreed to exercise the $1.00 Warrant in full for $1,000,000 cash, (ii) the expiration date of the warrant to purchase 500,000 shares of Common Stock at $1.50 per share (the "$1.50 Warrant") was extended from December 31, 2025 to December 31, 2026, (iii) the maturity date of the Convertible Note was extended from December 31, 2025 to December 31, 2026, (iv) the maturity date of the Prior Secured Note was extended to December 31, 2025, and (v) the Issuer agreed not to prepay more than $2,400,000 of principal outstanding under the Convertible Note prior to September 30, 2026 and not to make any prepayment under the Convertible Note while amounts remain outstanding under any non-convertible notes of the Issuer (excluding notes issued pursuant to equipment financing). A copy of the June 2025 Amendment was filed as Exhibit 10.1 to the Issuer's Current Report on Form 8-K filed on June 2, 2025 and is incorporated herein by reference. January 2026 Conversion. On January 28, 2026, Kaufman Kapital converted $500,000 of outstanding principal under the Convertible Note into 659,457 shares of Common Stock at the fixed conversion price of $0.7582 per share. January 2026 New Loan. On January 28, 2026, Kaufman Kapital loaned $1,500,000 to the Issuer pursuant to the New Secured Note. Current Plans and Purposes. The Reporting Persons currently hold the securities of the Issuer for investment purposes. The Reporting Persons continuously evaluate their investment in the Issuer based on a variety of factors, including the Issuer's financial condition, results of operations, business prospects, general market and economic conditions, and other factors. Depending on such evaluation, the Reporting Persons may from time to time acquire additional securities of the Issuer (including through conversion of outstanding Convertible Note principal and accrued interest or exercise of the $1.50 Warrant), dispose of some or all of the securities of the Issuer (including through open-market sales, privately negotiated transactions, block trades, registered offerings, or otherwise), or take any other action with respect to their investment in the Issuer as they may deem appropriate. Any such transactions may be effected at any time and from time to time, without prior notice, and will depend upon a variety of factors, including those described above. Except as otherwise described in this Amendment, the Reporting Persons do not have any present plans or proposals that relate to or would result in any of the matters described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.